Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,256.00    -24.00 (-1.88%)
Bid:
1,246.00
Ask:
1,258.00
Spread: 12.00 (0.963%)
Market Cap: £575.57m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Investor Presentation

11 Jul 2025 09:00

RNS Number : 6167Q
Cohort PLC
11 July 2025
 

One Waterside Drive

Arlington Business Park

Reading

Berks

RG7 4SW

 

11 July 2025

 

 

 

COHORT PLC

("Cohort", "the Company" or "the Group")

 

Cohort Investor Webinar

 

Investor Presentation via Equity Development

 

Cohort plc (the "Company") is pleased to announce that its Chief Executive, Andrew Thomis, and Finance Director, Simon Walther, will present its preliminary results for the year ended 30 April 2025. 

The webinar will take place on Friday 18th July, starting at 10.15am. The online presentation is open to all existing and potential shareholders and registration is free.

Questions can be submitted during the presentation and will be addressed by both speakers during the Q&A. To submit questions prior to the event please email them to info@equitydevelopment.co.uk

To attend the event, please register here:

 

https://us06web.zoom.us/webinar/register/WN_cwBwZAGgRWCBqsOA8crjJw#/registration

 

A recording will be made available shortly after the event by Equity Development.

For more information please contact: Equity Development Ltd. - Matt Evans 020 7065 2690

 

NOTES TO EDITORS

 

Cohort plc (www.cohortplc.com) is the parent company of seven innovative, agile and responsive businesses based in the UK, Australia, Germany and Portugal, providing a wide range of services and products for domestic and export customers in defence and related markets.

 

Cohort (AIM: CHRT) was admitted to London's Alternative Investment Market in March 2006. It has headquarters in Reading, Berkshire and employs in total over 1,500 core staff there and at its other operating company sites across the UK, Australia, Germany, and Portugal.

 

The Group is split into two divisions - Communications and Intelligence, and Sensors and Effectors:

 

Communications and Intelligence

· EID designs and manufactures advanced communications systems for naval and military customers. Cohort acquired a majority stake in June 2016. www.eid.pt

 

· EM Solutions designs, assembles, tests, and supports advanced mobile satellite communications terminals for naval and other customers. It also provides advanced radio frequency devices and subsystems for defence and commercial markets. Acquired by Cohort in January 2025. www.emsolutions.com.au

 

· MASS is a specialist data technology company serving the defence and security markets, focused on electronic warfare, digital services, and training support. Acquired by Cohort in August 2006. www.mass.co.uk

 

· MCL designs, sources, and supports advanced electronic and surveillance technology for UK end users including the MOD and other government agencies. MCL has been part of the Group since July 2014. www.marlboroughcomms.com

 

Sensors and Effectors

· Chess Dynamics offers multi-sensor surveillance, tracking and fire-control systems for defence customers. Chess has been part of the Group since December 2018. www.chess-dynamics.com

 

· ELAC SONAR supplies advanced sonar systems and underwater communications to global customers in the naval marketplace. Acquired by Cohort in December 2020. www.elac-sonar.de 

 

· SEA designs, delivers and supports technology-based products for naval surface ships and submarines. Acquired by Cohort in October 2007. https://www.sea.co.uk/

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAURAVRVSUBAAR
Date   Source Headline
1st Jun 202611:41 amRNSTotal Voting Rights
27th May 20267:00 amRNSFull Year Trading Update
26th May 20267:00 amRNSNotice of Full Year Trading Update
12th May 202610:46 amRNSHolding(s) in Company
1st May 20269:37 amRNSTotal Voting Rights
10th Apr 20263:58 pmRNSDirector/PDMR Shareholding
10th Apr 202612:35 pmRNSHolding(s) in Company
2nd Apr 20267:00 amRNSBlock Listing Six Monthly Return
1st Apr 202610:10 amRNSTotal Voting Rights
26th Mar 20267:00 amRNSContract Announcement
23rd Mar 20267:00 amRNSContract Announcement
2nd Mar 202611:57 amRNSTotal Voting Rights
25th Feb 20269:51 amRNSBlock Listing Six Monthly Return
20th Feb 20267:00 amRNSDirector/PDMR Shareholding
17th Feb 20263:41 pmRNSHolding(s) in Company
16th Feb 20267:00 amRNSDirector/PDMR Shareholding
4th Feb 20269:35 amRNSHolding(s) in Company
2nd Feb 20264:54 pmRNSTotal Voting Rights
30th Jan 20267:00 amRNSContract Wins
20th Jan 202612:40 pmRNSHolding(s) in Company
15th Jan 20267:00 amRNSInterim Report 2025
5th Jan 20269:00 amRNS-RInvestor Presentation via Equity Development
2nd Jan 202612:40 pmRNSTotal Voting Rights
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
15th Dec 202511:56 amRNSDirector/PDMR Shareholding
11th Dec 20257:00 amRNSDirector/PDMR Shareholding
10th Dec 20257:01 amRNSHalf Year Results
1st Dec 202512:20 pmRNSTotal Voting Rights
28th Nov 20257:00 amRNSNotice of Half Year Results
4th Nov 202511:59 amRNSTotal Voting Rights
27th Oct 20254:37 pmRNSDirector/PDMR Shareholding
16th Oct 202510:11 amRNSDirector/PDMR Shareholding
7th Oct 20253:15 pmRNSDirector/PDMR Shareholding
7th Oct 20257:00 amRNSMASS secures £15.7m countermeasures contract
2nd Oct 202511:03 amRNSBlock Listing Six Monthly Return
1st Oct 20259:53 amRNSTotal Voting Rights
25th Sep 20254:59 pmRNSResult of AGM
25th Sep 20257:00 amRNSAGM Statement
19th Sep 20255:12 pmRNSDirector/PDMR Shareholding
12th Sep 20257:00 amRNS-RInvestor Presentation
10th Sep 20253:21 pmRNSDirector/PDMR Shareholding
3rd Sep 202510:57 amRNSDirector/PDMR Shareholding
1st Sep 202511:05 amRNSTotal Voting Rights
26th Aug 20253:22 pmRNSBlock Listing Six Monthly Return
20th Aug 20253:56 pmRNSAnnual Report and Notice of Annual General Meeting
15th Aug 20253:35 pmRNSDirector/PDMR Shareholding
11th Aug 20255:10 pmRNSDirector/PDMR Shareholding
1st Aug 20254:16 pmRNSTotal Voting Rights
17th Jul 20259:49 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.